Media Center

New York (March 27, 2026) – The American Geriatrics Society (AGS) is pleased to announce the results of its 2026 AGS Board of Directors and Nominating Committee elections. AGS members elected Judith L. Beizer, PharmD, FASCP, AGSF to serve as AGS President-Elect. Dr. Beizer is on the faculty of St. John’s University College of Pharmacy and Health Sciences. Megan Young, MD (Boston Medical Center) was elected for a second term and Timothy Farrell, MD, AGSF (University of Utah) and Lisa Walke, MD, MSHA, AGSF (University of Pennsylvania) were elected to first terms on the Board. The members elected Sharon Brangman, MD, FACP, AGSF (State University of New York-Upstate) to serve on the AGS Nominating Committee.  

Earlier this year, the AGS Board elected the following as officers of the Society: 

Ramona Rhodes, MD, MPH, MSCS, AGSF, UT Southwestern Medical Center, to serve as AGS Treasurer for a second term, and Reena Karani, MD, MHPE, FACP, AGSF, Icahn School of Medicine at Mount Sinai, to serve as AGS Secretary for a first term.

The AGS Board also appointed the following to first terms as members of the AGS Nominating Committee: 

• From angiotensin receptor-neprilysin inhibitor exposure to a pragmatic pharmacist-led deprescribing intervention, & validating measures between the electronic health record and Medicare Claims #geriatrics research is shaping the future of care for all of us as we age. Don’t miss this year’s Plenary Paper session at #AGS26.  https://bit.ly/3PtWRuS 

New York (March 25, 2026) – Researchers presenting at the American Geriatrics Society (AGS) Virtual Annual Scientific Meeting (#AGS26), taking place April 30^th – May 2^nd (pre-conference days Monday, April 27^th – Wednesday, April 29^th), represent the leading voices in geriatrics scholarship. Selected from a highly competitive pool of 746 submissions, this year’s Plenary Paper Presenters will showcase innovative research aimed at advancing the health and well-being of older adults. The #AGS26 Plenary Paper Session (Thursday, April 30th, 11:15–12:00 PM EST) will feature distinguished speakers that will highlight the wide-ranging impact of geriatrics research, demonstrating its critical role in shaping the future of caring for all of us as we age.

Sacubitril/Valsartan Use across Transitions between Community, Hospital, and Skilled Nursing Facility Settings (presented by Andrew R. Zullo, PharmD, PhD)

New York (September 8, 2025) - The American Geriatrics Society (AGS) enthusiastically supports the introduction of the Geriatrics Workforce Improvement Act (S. 2699), which was introduced in the Senate on September 3rd.  

Spearheaded by Senators Susan Collins (R-ME) and Tim Kaine (D-VA), members of the Health, Education, Labor and Pensions (HELP) Committee, this legislation would reauthorize funding for the Geriatrics Workforce Enhancement Program (GWEP) and the Geriatrics Academic Career Awards (GACA).

As Americans live longer, our healthspans can vary significantly and many of us will be diagnosed with chronic diseases as we age. Geriatrics health professionals are experts in preventing, delaying, and managing the chronic diseases that impact many Americans 65 and older. Yet, there are too few such practitioners in the U.S. to meet the needs of older Americans.

The GWEP and GACA Program are the only federal programs designed to address the geriatrics workforce gap through geriatrics training at the community level (GWEP) and increase the number of faculty with geriatrics expertise across disciplines who can integrate geriatrics principles into health professional training (GACA). Administered by the Health Resources and Services Administration (HRSA), the GWEP and GACA programs are building the geriatrics expertise we need in the primary care, paid caregiver, and family caregiver workforce.

New York (August 5, 2025) – On July 31, 2025, the Centers for Disease Control and Prevention (CDC) notified all organizational liaisons to the Advisory Committee on Immunization Practices (ACIP) that they were no longer eligible to serve as members of work groups established by ACIP to consider published and unpublished evidence on vaccine efficacy and safety. These work groups serve an important function in the development of recommendations to ACIP as to which vaccines should be on the vaccination schedules for children and adults, including older adults. In its notification, CDC conveyed that this decision is being made because CDC believes that organizational liaisons are inherently biased as they represent special interest groups. 

The AGS mission is to improve the health, independence, and quality of life of all older adults. We are committed to ensuring federal policy impacting the health of older Americans is informed by geriatrics health professionals who have the clinical and scientific expertise that is needed to guide development of healthcare policies. We believe vaccines are essential to preventing or lessening the impact of infectious diseases on older adults given our immune systems weaken as we age. These impacts can include exacerbation of chronic conditions, acceleration of disability (e.g., a prolonged hospital stay for pneumonia could result in decreased mobility and increased need for assistance with activities of daily living), or hastening the death of older Americans. 

• Today, @AmerGeriatrics released the Alternative Treatments to Selected Medications in the 2023 American Geriatrics Society Beers Criteria^® (DOI: 10.1111/jgs.19500) in the Journal of the American Geriatrics Society (JAGS). 

New York (July 23, 2025) — Today the American Geriatrics Society (AGS) announced the release of the Alternative Treatments to Selected Medications in the 2023 American Geriatrics Society Beers Criteria^® (DOI: 10.1111/jgs.19500), an updated clinical resource d